NCT03221959

Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.

Name: Clinical Trial NCT03221959
Creator: Kienzler Jenny
Keywords: Intracranial Pressure Increase, Medical Device Vittamed 205, device, clinical trial

Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Decompressive Craniectomy

Kienzler Jenny·ClinicalTrials.gov·device·Device trial

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Intracranial Pressure Increase
Drug/Device/Intervention: Medical Device Vittamed 205
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: Kienzler Jenny
Funder: Kantonsspital Aarau

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2018
End date: Dec 01, 2020
Enrollment: 48 participants

Primary outcome

non-invasive ICP) measurement im mmHg

Summary

This is a single centre, observational study with a medical device which has Conformité Européenne (CE) marking. The aim of the study is to demonstrate that patients with malignant middle cerebral artery infarction (M-MCA) show an increased intra-cranial pressure (ICP) compared to neurological patients without M-MCA infarction or other space-occupying indications.

ICD-10 classifications

Benign intracranial hypertensionIntracranial injuryIntracranial injury, unspecifiedOther intracranial injuriesIntracranial hypotension following ventricular shunting

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03221959
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT03221959 through Pure Global AI's free database. This phase not specified trial is sponsored by Kienzler Jenny and is currently status unknown. The study focuses on Intracranial Pressure Increase. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.